U.S. Physical Therapy, Inc.
USPH
$80.27
-$1.74-2.12%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 598.53M | 574.89M | 553.64M | 535.31M | 523.60M |
| Total Other Revenue | 123.68M | 117.43M | 110.79M | 103.76M | 97.63M |
| Total Revenue | 722.20M | 692.33M | 664.43M | 639.06M | 621.23M |
| Cost of Revenue | 554.73M | 533.49M | 510.03M | 489.79M | 476.57M |
| Gross Profit | 167.47M | 158.84M | 154.41M | 149.27M | 144.67M |
| SG&A Expenses | 63.68M | 60.45M | 58.29M | 56.62M | 54.28M |
| Depreciation & Amortization | 29.13M | 27.69M | 26.04M | 23.14M | 23.14M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 647.54M | 621.63M | 594.35M | 569.56M | 553.99M |
| Operating Income | 74.66M | 70.70M | 70.08M | 69.51M | 67.24M |
| Income Before Tax | 70.64M | 62.78M | 60.21M | 41.99M | 45.44M |
| Income Tax Expenses | 17.18M | 15.33M | 14.61M | 10.18M | 11.18M |
| Earnings from Continuing Operations | 53.46 | 47.45 | 45.60 | 31.81 | 34.26 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -15.30M | -14.17M | -14.18M | -8.98M | -8.80M |
| Net Income | 38.16M | 33.28M | 31.42M | 22.84M | 25.46M |
| EBIT | 74.66M | 70.70M | 70.08M | 69.51M | 67.24M |
| EBITDA | 96.66M | 91.15M | 88.76M | 86.62M | 83.93M |
| EPS Basic | 2.29 | 2.17 | 1.84 | 0.93 | 1.06 |
| Normalized Basic EPS | 1.81 | 1.79 | 1.85 | 2.35 | 2.28 |
| EPS Diluted | 2.29 | 2.17 | 1.84 | 0.93 | 1.06 |
| Normalized Diluted EPS | 1.81 | 1.79 | 1.85 | 2.35 | 2.28 |
| Average Basic Shares Outstanding | 60.50M | 60.37M | 60.26M | 60.15M | 60.06M |
| Average Diluted Shares Outstanding | 60.50M | 60.37M | 60.26M | 60.15M | 60.06M |
| Dividend Per Share | 1.78 | 1.77 | 1.76 | 1.75 | 1.74 |
| Payout Ratio | 70.63% | 79.75% | 84.46% | 115.36% | 102.72% |